siponimod (Mayzent) Report issue

Small molecule Approved FDA Priority Review FDA
AACT ChEMBL DrugBank MeSH PubChem
Back

Drug Pricing Summary

AUS PBS

$13.6481 - $58.4917

VA Big4

$47.2636 - $189.1930

VA FSS

$47.2642 - $253.2303

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
siponimod 0.25 mg (TABLET) $47.2636 VA Big4
  • MAYZENT (28)
    		•  Novartis Pharmaceuticals Corporation
    siponimod 0.25 mg (TABLET) $47.2642 VA FSS
  • MAYZENT (12)
    		•  Novartis Pharmaceuticals Corporation
    siponimod 0.25 mg (TABLET) $63.3075 VA FSS
  • MAYZENT (28)
    		•  Novartis Pharmaceuticals Corporation
    siponimod 250 ug (TABLET) $13.6481 AUS PBS generic
  • Mayzent (120)
    		•  Novartis Pharmaceuticals Australia Pty Limited
    siponimod 250 ug (TABLET) $14.2985 AUS PBS generic
  • Mayzent (12)
    		•  Novartis Pharmaceuticals Australia Pty Limited
    siponimod 2 mg (TABLET) $58.4917 AUS PBS generic
  • Mayzent (28)
    		•  Novartis Pharmaceuticals Australia Pty Limited
    siponimod 2 mg (TABLET) $189.1930 VA Big4
  • MAYZENT (30)
    		•  Novartis Pharmaceuticals Corporation
    siponimod 2 mg (TABLET) $253.2303 VA FSS
  • MAYZENT (30)
    		•  Novartis Pharmaceuticals Corporation

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue